Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenal Insufficiency in Hospitalized Cirrhosis
NCT03368066Phase 3Completed
- Sponsor
- University of Virginia
- Start
- Jan 2018
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by University of Virginia. Primary endpoints: Number of Participants With Cholesterol Esterification Deficiency at 24 hours, Number of Participants With Spur Cell Anemia at 24 hours and 1 more. Started Jan 2018; status: completed.
Beyond the preview
Go deeper on NCT03368066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03368066.